Ro Body
Ro
Brand-name GLP-1s with a dedicated insurance team that files prior authorisations for you
- Membership
- from $74/mo
- Medication
- Billed separately
Advertising disclosure: We earn commissions from some of the products we link to. It never changes our scores or what we publish. Read the full disclosure
Shapely
Shapely is built around getting brand-name GLP-1s covered by insurance rather than selling compounded medication as the default. It publishes a membership fee, staffs a prior authorisation team, includes monthly video visits with a provider and a registered dietitian, and lists the insurers it works with. It also sells compounded semaglutide and tirzepatide self-pay for people who cannot get coverage. The catch is geography: at capture it served four states.
Sources captured · researched by Tom
As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.
Shapely publishes 9 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers
These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.
Someone in California, Florida, New York or Texas with commercial or Medicare coverage who wants a brand-name GLP-1 through insurance and help fighting the prior authorisation, rather than a cash-pay compounded product.
The order of operations. Shapely leads with brand-name medication through insurance — it lists the plans it works with, states Medicare and major PPO coverage, and staffs prior authorisation specialists to file the paperwork. Compounded semaglutide and tirzepatide are offered as a self-pay fallback rather than the main product. Most of this directory works the other way round.
Only if you are in California, Florida, New York or Texas. The site states those four states at capture and says it plans to expand to all fifty. This is the single biggest limitation on an otherwise unusually well-documented service, so check before you invest time in the intake.
The site says labs are strongly recommended but not required, that it will order them or accept results from the previous six months, and that they are typically covered by insurance with a possible co-pay. Without insurance it publishes a flat $75 through a Labcorp draw. Publishing an actual number here is rare enough to be worth noting.
Orforglipron, Eli Lilly's oral GLP-1 for chronic weight management — a pill rather than an injection. Shapely publishes it at as little as $25 a month with commercial coverage, or from $149 a month self-pay. Very few providers in this directory list it at all, and the figures here come from Shapely's own page rather than from us.
Captured . Pages change — check the current version before relying on anything here.
Ro
Brand-name GLP-1s with a dedicated insurance team that files prior authorisations for you
Found Health
Offers both compounded and brand-name routes, plus a Medicare Part D bridge programme
LifeMD
Low-cost general telehealth membership with weight management layered on top